Ethnic Neutropenia and Treatment Delay in African American Women Undergoing Chemotherapy for Early-Stage Breast Cancer

Dawn L. Hershman, Mitchell Weinberg, Zachary Rosner, +5

JNCI Journal of the National Cancer Institute

36-Year-Old Female with Catastrophic Antiphospholipid Syndrome Treated with Eculizumab: A Case Report and Review of Literature

Marianna Strakhan, Mariana Hurtado-Sbordoni, Nahun Galeas, +3

Case Reports in Hematology

ImmunologyPathologyThrombosisTranslational MedicineCatastrophic Antiphospholipid Syndrome +18

High absolute lymphocyte counts are associated with longer overall survival in patients with metastatic breast cancer treated with eribulin—but not with treatment of physician’s choice—in the EMBRACE study

Yasuo Miyoshi, Yuta Yoshimura, Kenichi Saito, +9

Breast Cancer

Innate Cell Engager AFM13 Combined with Preactivated and Expanded Cord Blood-Derived NK Cells for Patients with Double Refractory CD30+ Lymphoma

Yago Nieto, Pinaki P. Banerjee, Indreshpal Kaur, +20

Blood

Innate Cell Engager (ICE®) AFM13 Combined with Preactivated and Expanded (P+E) Cord Blood (CB)-Derived Natural Killer (NK) Cells for Patients with Refractory CD30-Positive Lymphomas: Final Results

Yago Nieto, Pinaki P. Banerjee, Indreshpal Kaur, +21

Blood

Observational Study of Clinical Outcomes of Eribulin Mesylate in Metastatic Breast Cancer After Cyclin-Dependent Kinase 4/6 Inhibitor Therapy

Sarah S. Mougalian, Bruce A. Feinberg, Karenza Alexis, +6

Future Oncology

Abstract CT003: Innate cell engager (ICE®) AFM13 combined with preactivated and expanded cord blood (CB)-derived NK cells for patients with refractory/relapsed CD30+ lymphoma

Yago Nieto, Pinaki P. Banerjee, Indreshpal Kaur, +17

Cancer Research

ImmunodeficienciesImmunologyImmune RegulationRefractory/relapsed Cd30+ LymphomaImmunoediting +17

Abstract CT024: REDIRECT: A Phase 2 study of AFM13 in patients with CD30-positive relapsed or refractory (R/R) peripheral T cell lymphoma (PTCL)

Won Seog Kim, Jake Shortt, Pier Luigi Zinzani, +12

Cancer Research

ImmunodeficienciesImmunologyImmune RegulationPathologyImmunoediting +20

Efficacy of eribulin for metastatic breast cancer based on localization of specific secondary metastases: a post hoc analysis

Joyce O’Shaughnessy, Javier Cortés, Chris Twelves, +5

Scientific Reports

Metastatic Breast CancerAdvanced/metastatic Breast CancerBreast OncologyMedicineObjective Response Rate +9

Acquired Von Willebrand’s Syndrome in Systemic Lupus Erythematosus

Sara Taveras Alam, Karenza Alexis, Ashwin Sridharan, +4

Case Reports in Hematology

Gastrointestinal BleedingThrombosisAutoimmune DiseaseVasculitisSystemic Lupus Erythematosus Treatment +13